peptide elongation factor 2 has been researched along with tacrolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gschwendt, M; Kittstein, W; Marks, F | 1 |
| Sans, MD; Williams, JA | 1 |
2 other study(ies) available for peptide elongation factor 2 and tacrolimus
| Article | Year |
|---|---|
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo.
Topics: Animals; Binding Sites; Calmodulin; Cyclosporins; Depsipeptides; Female; Immunosuppressive Agents; In Vitro Techniques; Mice; Peptide Elongation Factor 2; Peptide Elongation Factors; Peptides, Cyclic; Phosphorylation; Pyridines; Skin; Tacrolimus; Tetradecanoylphorbol Acetate | 1989 |
Calcineurin is required for translational control of protein synthesis in rat pancreatic acini.
Topics: Animals; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cholecystokinin; Cyclosporine; Elongation Factor 2 Kinase; Eukaryotic Initiation Factor-2B; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4F; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Pancreas; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6; RNA Cap-Binding Proteins; Tacrolimus | 2004 |